Clearia.

All notes

Notes · payer data

Florida prior authorization scorecard: what the payers' own 2025 filings show

Published August 10, 2026 · built from the payers' first-ever CMS-0057 disclosures, retrieved August 10, 2026

As of March 31, 2026, a federal rule (CMS-0057-F) requires Medicare Advantage plans, Medicaid managed-care plans, and marketplace insurers to publish their own prior authorization report cards: how many requests they received, how many they approved and denied, how many denials they reversed on appeal, and how fast they decide. The first filings — covering calendar year 2025 — are now on the payers' websites, each in its own format, in its own corner.

We pulled the primary filings for the payers that matter most to Florida specialty practices and extracted every number. This page is the comparison the filings don't give you. Every figure below comes from the payer's own posting; sources are listed at the bottom.

Read this first: these are self-reported, first-year numbers, and payers aren't perfectly comparable — they serve different members and gate different services. UnitedHealthcare's own filing notes that "not approved" includes administrative reasons like missing documentation, not only clinical denials. Read the table as a starting point with sources you can verify, not a verdict.

Medicare Advantage: the company-wide picture

Standard (non-urgent) prior authorization requests, calendar year 2025, aggregated across each payer's Medicare Advantage contracts. Where the payer disclosed request volumes, the denial rate is volume-weighted from its per-contract data; where it disclosed only percentages, we report a simple average across contracts.

PayerContracts filedStd requestsDenial rateDenials overturned on appeal
UnitedHealthcare617.9M13.5%~55% (varies 19–88% by contract)
Aetna42not disclosed~8.4% (simple avg)~87% (simple avg)
Florida Blue Medicare (H1035 HMO / H5434 PPO)2not disclosed8–9%55–56%
Humana329.5M6.9%64.7% (volume-weighted)

The headline sits in the first and last rows: by their own filings, UnitedHealthcare denied standard Medicare Advantage prior auth requests at roughly twice Humana's rate — 13.5% versus 6.9%, volume-weighted across 17+ million requests. And the company averages hide wide internal spreads: individual UHC contracts range from under 2% to over 23% denied.

The Florida slices

Some filings resolve to Florida directly — state-level lines of business and Florida-specific contracts. These are the rows closest to what a Florida practice actually bills against:

Payer · line of businessStd requestsDenial rateOverturned on appeal
UnitedHealthcare · FL marketplace (ACA)21,21822.3%41.8% — of just 23 appeals filed
UnitedHealthcare · FL Medicaid (MMA)70,55813.9%78.0%
UnitedHealthcare · FL Medicaid long-term care43,0269.5%100% — 5 appeals filed, 5 won
Humana · FL Medicaid746,9742.6%7.6%
Florida Blue · marketplace (BlueOptions/BlueSelect)not disclosed5%28%
Florida Blue · marketplace (myBlue/BlueCare HMO)not disclosed1%30%
Florida Blue · Medicare Advantage (HMO / PPO)not disclosed9% / 8%55% / 56%

The row worth rereading is the first one. On UnitedHealthcare's Florida marketplace plans, 4,732 standard requests were denied in 2025 — and 23 of those denials were appealed. That is one appeal per two hundred denials, on a book where 42% of the appeals that were filed won.

The appeal gap is the story

Across every filing we extracted, the same shape repeats: denials are common, appeals are rare, and appeals win at rates no one would call a longshot. Humana's Medicare Advantage contracts decided 17,690 appeals in 2025 and reversed 64.7% of them — against roughly 650,000 denials. Aetna's contracts report reversing over 80% of appealed denials on most contracts. Federal watchdog reports have found the same pattern for years (75–97% of appealed Medicare Advantage denials overturned, depending on service type).

A denial that would be reversed if challenged, and never is, doesn't show up anywhere as an error. It shows up as a write-off on a practice's books. The filings above put payer-published numbers on how much of that reversal capacity goes unused — which is precisely the gap a disciplined appeal operation works.

Prior auth is only half the fight

A low prior authorization denial rate does not mean claims get paid. Florida Blue's marketplace filings report PA denial rates of 1–5% — while KFF's analysis of federal transparency data puts Florida Blue among the highest in-network claim denial rates on marketplace plans, at 20%+. The authorization is approved; the claim is then denied or reduced at adjudication — bundling edits, downcoding, documentation requests, underpayment against the contracted rate.

That second fight happens on the remittance, after the service, and it's where recovery work lives. The prior auth scorecard tells you how a payer behaves at the gate; the remittance data tells you what happened to the dollars.

Who disclosed well — and who didn't

PayerDisclosure quality
HumanaBest in class: full request and appeal volumes per contract, plus per-state Medicaid files, all as downloadable PDFs
UnitedHealthcareStrong: per-contract volumes for Medicare Advantage, state-level rows for marketplace and Medicaid
AetnaPercentages only — no request volumes anywhere in an 84-page filing, which makes its rates impossible to weight
Florida BlueSummary web page only: rounded percentages by product, no volumes, no downloadable file
CignaA Florida posting could not be located as of August 10, 2026 (state disclosures exist for other states)

Granularity is itself a signal. The rule requires the metrics; it doesn't require making them easy to compare. First-year compliance ranged from genuinely transparent to the bare minimum.

What this means for a Florida practice

Sources and method

All figures extracted August 10, 2026 from the payers' public CMS-0057 postings: Humana's prior authorization metrics (per-contract PDFs), UnitedHealthcare's CMS interoperability disclosures (Medicare Advantage, marketplace, and community plan files), Florida Blue's metrics page, and Aetna's 2025 PA metrics report (PDF posted on aetna.com). Company denial rates are volume-weighted where volumes were disclosed. "Overturned on appeal" is the share of decided appeals that reversed the denial — not the share of all denials. Calendar year 2025 data throughout; reporting timeframes and definitions follow each payer's filing.

Want to know what your payers' behavior cost your practice? That's Clearia's diagnostic: your remittance data audited claim by claim against contracts, fee schedules, and Florida's deadlines — findings in dollars, at no cost. We're paid only from what we recover.

Request the free diagnostic